ACXP vs RNAZ

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 23, 2026

ACXP

48.5
AI Score
VS
ACXP Wins

RNAZ

47.8
AI Score

Investment Advisor Scores

ACXP

49score
Recommendation
HOLD

RNAZ

48score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ACXP RNAZ Winner
Net Income -3.94M -24.54M ACXP
Operating Income -4.02M -24.54M ACXP
ROE -48.3% 88.6% RNAZ
ROA -35.8% -16.2% RNAZ
Total Assets 10.98M 151.01M RNAZ
Cash 14.46M 8.38M ACXP
Current Ratio 2.17 1.97 ACXP

Relative Price Performance (Last 90 Days)

ACXP 1M: -16.3% · 3M: -20.3% RNAZ 1M: +8.5% · 3M: -67.2%

Current Technical Phase

ACXP

Markdown
Sell / avoid

Price below a falling SMA50 (slope -6.8%), weak momentum, RSI 34

RSI (14): 33.6 · Price: $1.14

RNAZ

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 45.8 · Price: $1.79

Fundamentals Snapshot

Metric ACXP RNAZ
Market Cap — —
Forward P/E -0.7 -5.4
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin — —
Operating Margin 0.0% 0.0%
EPS -2.67 -52.06
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ACXP is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.